Who are Cortancyl Oral Tablet's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Methylprednisolone/prednisolone, Prednisone 1 week, Placebo Prednisolone, Solu-Cortef, methylprednisolone, prednisolone, prednisone, Oral Prednisone.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/cortancyl-oral-tablet.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Cortancyl Oral Tablet — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cortancyl Oral Tablet (Cortancyl Oral Tablet) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid (glucocorticoid). Area: Immunology / Rheumatology / General Anti-inflammatory.

phase 3 Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR) Immunology / Rheumatology / General Anti-inflammatory Small molecule Live · refreshed every 30 min

Target snapshot

Cortancyl Oral Tablet (Cortancyl Oral Tablet) — Assistance Publique - Hôpitaux de Paris. Cortancyl is a corticosteroid that suppresses immune and inflammatory responses by binding to glucocorticoid receptors.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Cortancyl Oral Tablet TARGET	Cortancyl Oral Tablet	Assistance Publique - Hôpitaux de Paris	phase 3	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Methylprednisolone/prednisolone	Methylprednisolone/prednisolone	Chong Kun Dang Pharmaceutical	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Prednisone 1 week	Prednisone 1 week	Xinqiao Hospital of Chongqing	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Placebo Prednisolone	Placebo Prednisolone	Milton S. Hershey Medical Center	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Solu-Cortef	Solu-Cortef	Haukeland University Hospital	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
methylprednisolone, prednisolone, prednisone	methylprednisolone, prednisolone, prednisone	University of California, San Francisco	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Oral Prednisone	Oral Prednisone	Assistance Publique - Hôpitaux de Paris	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid (glucocorticoid) class)

Assistance Publique - Hôpitaux de Paris · 3 drugs in this class
Astellas Pharma Inc · 2 drugs in this class
Sanofi · 2 drugs in this class
Xinqiao Hospital of Chongqing · 2 drugs in this class
Berinstein, Jeffrey · 2 drugs in this class
Ain Shams University · 2 drugs in this class
Children's Hospital of Philadelphia · 1 drug in this class
Celgene · 1 drug in this class
Hamilton Health Sciences Corporation · 1 drug in this class
Erasme University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Cortancyl Oral Tablet — Competitive Intelligence Brief. https://druglandscape.com/ci/cortancyl-oral-tablet. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing